MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
Relmada Therapeutics Historical Prices 2011-2026 | RLMD
Annual Historical Prices Relmada Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.37 | 2.41 | 20.5 | 33.3 | 48.8 | 5.32 | 2.8 | 3.24 | 6 | 54.8 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 54.8 | 2.41 | 18.3 |
Historical Prices of other stocks in the Drug manufacturers industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aerie Pharmaceuticals
AERI
|
7.02 | - | - | $ 754 M |  USA |
 |
AcelRx Pharmaceuticals
ACRX
|
0.86 | - | 7.5 % | $ 6.35 M | USA |
 |
Catalent
CTLT
|
60 | - | - | $ 11.5 B | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
0.12 | - | 0.86 % | $ 117 M | USA |
 |
DURECT Corporation
DRRX
|
1.21 | - | - | $ 50.1 M | USA |
 |
Canopy Growth Corporation
CGC
|
1.32 | $ 1.12 | 5.19 % | $ 120 M |  Canada |
 |
Endo International plc
ENDP
|
0.29 | - | - | $ 28.9 M |  Irlanda |
 |
Agile Therapeutics
AGRX
|
0.6 | - | 10.11 % | $ 58.2 M | USA |
 |
Evoke Pharma
EVOK
|
0.67 | - | - | $ 36.6 M | USA |
 |
Alimera Sciences
ALIM
|
3.97 | - | - | $ 142 M | USA |
 |
Cronos Group
CRON
|
3.69 | $ 2.67 | 2.5 % | $ 1.38 B | Canada |
 |
Evolus
EOLS
|
4.21 | $ 5.34 | 29.21 % | $ 344 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
7.54 | - | - | $ 2.06 B |  France |
 |
Jupiter Wellness
JUPW
|
1.52 | - | - | $ 33.6 M | USA |
 |
China Pharma Holdings
CPHI
|
0.26 | $ 0.57 | 0.79 % | $ 9.95 M |  China |
 |
Cumberland Pharmaceuticals
CPIX
|
6.3 | $ 4.44 | -3.06 % | $ 62.4 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
19.7 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
0.71 | - | 2.45 % | $ 38.1 M | Canada |
 |
Neoleukin Therapeutics
NLTX
|
3.49 | - | - | $ 193 M | Canada |
 |
Aurora Cannabis
ACB
|
4.08 | $ 3.7 | 6.32 % | $ 86.3 M | Canada |
 |
Harrow Health
HROW
|
52.6 | $ 40.3 | 4.39 % | $ 1.48 B | USA |
 |
Athenex
ATNX
|
1.75 | - | -23.39 % | $ 1.76 M | USA |
 |
Emergent BioSolutions
EBS
|
2.71 | $ 8.91 | 0.06 % | $ 456 M | USA |
 |
ProPhase Labs
PRPH
|
8.24 | - | - | $ 5.07 M | USA |
 |
Assertio Holdings
ASRT
|
0.93 | $ 12.18 | 2.4 % | $ 865 M | USA |
 |
Radius Health
RDUS
|
8.32 | - | - | $ 1.42 B | USA |
 |
Bausch Health Companies
BHC
|
9.27 | $ 5.62 | -1.75 % | $ 2.05 B | Canada |
 |
Lannett Company
LCI
|
0.57 | - | 1.15 % | $ 7.11 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
26.3 | - | -39.89 % | $ 27.7 M | USA |
 |
Organogenesis Holdings
ORGO
|
3.15 | $ 2.92 | 1.57 % | $ 384 M | USA |
 |
OrganiGram Holdings
OGI
|
1.58 | $ 1.4 | 2.17 % | $ 402 M | Canada |
 |
Rockwell Medical
RMTI
|
1.52 | $ 0.9 | 0.18 % | $ 21 M | USA |
 |
Perrigo Company plc
PRGO
|
14.2 | $ 11.74 | 3.12 % | $ 1.63 B | USA |
 |
Sundial Growers
SNDL
|
1.45 | $ 1.56 | 1.63 % | $ 3.37 M | Canada |
 |
TherapeuticsMD
TXMD
|
2.29 | $ 2.26 | 1.77 % | $ 23.6 M | USA |
 |
Veru
VERU
|
0.8 | $ 2.66 | 5.56 % | $ 359 M | USA |
 |
Viatris
VTRS
|
15.3 | $ 14.89 | - | $ 17.9 B | USA |
 |
Pacira BioSciences
PCRX
|
25.5 | $ 22.5 | 1.81 % | $ 1.04 B | USA |
 |
PetIQ
PETQ
|
13.6 | - | 1.64 % | $ 400 M | USA |
 |
OptiNose
OPTN
|
1.71 | - | - | $ 1.08 B | USA |
 |
PLx Pharma
PLXP
|
5.05 | - | -27.8 % | $ 2.56 M | USA |
 |
Recro Pharma
REPH
|
1.4 | - | -4.76 % | $ 65.3 M | USA |
 |
cbdMD
YCBD
|
0.39 | $ 0.83 | 7.46 % | $ 3.58 M | USA |
 |
SCYNEXIS
SCYX
|
1.47 | $ 0.74 | -1.56 % | $ 35.4 M | USA |
 |
Solid Biosciences
SLDB
|
5.53 | $ 6.09 | 2.18 % | $ 249 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
2.95 | $ 2.77 | 0.65 % | $ 3.44 M | USA |
 |
Tricida
TCDA
|
7.96 | - | - | $ 3.25 M | USA |
 |
Tilray
TLRY
|
1.93 | $ 7.54 | 2.38 % | $ 4.66 B | Canada |
 |
Zynerba Pharmaceuticals
ZYNE
|
0.44 | - | - | $ 55.5 M | USA |